Original Research
Published on 06 Jan 2025
Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1504809
- 794 views
Type at least 3 characters
1,832 articles
Original Research
Published on 06 Jan 2025
Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unit
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1508112
- 1,218 views
Case Report
Published on 06 Jan 2025
Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1407893
- 594 views
Review
Published on 24 Dec 2024
BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1463505
- 1,348 views
Case Report
Published on 19 Dec 2024
Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1477697
- 1,122 views
Case Report
Published on 17 Dec 2024
Obinutuzumab-induced acute thrombocytopenia: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1509567
- 1,004 views
Clinical Trial
Published on 16 Dec 2024
A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1449401
- 1,213 views
Case Report
Published on 12 Dec 2024
Chronic myelogenous leukemia coexpressing V-e16a2, V-e13a2, e13a2, and e14a2 BCR::ABL1 fusion transcripts: a case report and review of the literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1518387
- 663 views
Correction
Published on 11 Dec 2024
Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1504102
- 551 views
Case Report
Published on 11 Dec 2024
Preoperative diagnosis of primary ovarian lymphoma: a case report and a decade of insights
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1471654
- 619 views
Case Report
Published on 10 Dec 2024
Severe atypical skin disease in two patients with CLL/SLL after BTKi treatment - a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1467891
- 897 views
Case Report
Published on 10 Dec 2024
Case report: Identification of a novel TOR1AIP2::ETV6 transcript with FLT3-ITD mutation in acute myeloid leukemia progressed from myelodysplastic syndrome
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1466590
- 767 views
Case Report
Published on 10 Dec 2024
Burkitt lymphoma after adult liver transplantation: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1439137
- 860 views
- 1 citation
Editorial
Published on 10 Dec 2024
Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1527836
- 627 views
Original Research
Published on 09 Dec 2024
Efficacy and safety of hypomethylating agents in the treatment of AML/MDS patients relapsed post allogenetic hematopoietic stem cell transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1465334
- 1,109 views
Original Research
Published on 09 Dec 2024
DL-ICE as a bridge to allogeneic transplantation in relapsed/refractory PTCL: survival outcomes and prognostic factors
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1461268
- 932 views